NEXT Molecular Analytics continues a 23 year history in providing comprehensive integrated project support to investigators in the biotech and pharmaceutical sectors. We also provide medical testing services to physicians using state-of-the-art platforms. NEXT Molecular Analytics was founded by three long standing colleagues who have worked together these past 23 years and collectively represent more than 100 years’ experience in life science technologies.
NEXT Molecular Analytics is focused in (1) clinical testing using molecular and biochemical techniques; (2) molecular genetics of pharmacogenomics and cancer; (3) contract research in drug discovery and development with private sector customers; and (4) laboratory support of human clinical trials. We function as an extension of your own laboratory in helping you to bring their products from discovery to market.
NEXT Molecular Analytics provides comprehensive analysis of large and small molecule biologics. We have extensive experience in implementing and validating complex mass spec, HPLC, GC/MS, and ELISA protocols, and have used these protocols to detect and confirm target analytes in complex matrices, including plasma, serum, urine, fecal matter, cell culture fluids, and the like.
NEXT Molecular Analytics has developed an extensive catalog of molecular diagnostic capabilities. Innovative science drives this program and enables us to provide solutions to some of the most vexing problems facing life science investigators.
Comprehensive service offering. Cloning, QPCR, DNA/RNA sequence analysis, Next Generation Sequencing, custom assay design, prep and extraction. Call for quote
NEXT Molecular Analytics has not received any reviews.
NEXT Molecular Analytics has not received any endorsements.